Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammers, A.
Right arrow Articles by Duncan, J.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammers, A.
Right arrow Articles by Duncan, J.S.
Neurology 2001;56:897-906
© 2001 American Academy of Neurology


Articles

Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy

A. Hammers, MD;, M.J. Koepp, PhD;, C. Labbé, PhD;, D.J. Brooks, FRCP;, M. Thom, MRCPath;, V.J. Cunningham, DPhil; and J.S. Duncan, FRCP

From the National Society for Epilepsy and Institute of Neurology (Drs. Hammers, Koepp, and Duncan), Queen Square, London; MRC Clinical Sciences Centre (Drs. Hammers, Koepp, Labbé, Brooks, and Cunningham), Imperial College School of Medicine, Hammersmith Hospital, London; and Department of Neuropathology (Dr. Thom), Institute of Neurology, Queen Square, London, United Kingdom.

Address correspondence and reprint requests to Prof. John S. Duncan, National Society for Epilepsy and Institute of Neurology, 33 Queen Square, London WC1N 3BG, UK; e-mail: j.duncan{at}ion.ucl.ac.uk

OBJECTIVE: To characterize abnormalities in neocortical central benzodiazepine receptor (cBZR) binding in patients with mesial temporal lobe epilepsy (mTLE) with unilateral hippocampal sclerosis (HS) using [11C]-flumazenil-(FMZ) PET and complementary voxel-based and quantitative volume-of-interest (VOI) methods.

METHODS: The authors studied 13 control subjects and 15 patients with refractory mTLE and unilateral HS with [11C]-FMZ PET. Data were corrected for partial volume effect in the interactively outlined hippocampus and in 28 cortical VOI using an individualized template. A voxel-based analysis was also performed using statistical parametric mapping (SPM).

RESULTS: Fourteen patients with mTLE had reduced [11C]-FMZ volume distribution (Vd) in the hippocampus ipsilateral to the EEG focus, extending into the amygdala in four. Five patients showed additional significant neocortical abnormalities of [11C]-FMZ binding: temporal neocortical increases (1), extratemporal decreases (2), extratemporal increases only (1), and temporal and extratemporal neocortical increases (1). Group VOI analysis revealed significant reductions only in the ipsilateral hippocampus. SPM showed decreased [11C]-FMZ-Vd in the ipsilateral hippocampus in 13 of 15 patients, extending into the amygdala in eight. Five patients showed additional neocortical abnormalities: temporal neocortical increases only (3), extratemporal decreases (1), or both temporal neocortical and extratemporal decreases (1). Group analysis showed significant reductions in the ipsilateral hippocampus only.

CONCLUSIONS: A combination of VOI- and voxel-based analysis of [11C]-FMZ PET detected extrahippocampal changes of cBZR binding in eight of 15 patients with mTLE due to HS. The finding of abnormalities in patients who were thought to have unilateral HS only based on MRI suggests that more widespread abnormalities are present in HS.




This article has been cited by other articles:


Home page
JNMHome page
H. Kato, E. Shimosegawa, N. Oku, K. Kitagawa, H. Kishima, Y. Saitoh, A. Kato, T. Yoshimine, and J. Hatazawa
MRI-Based Correction for Partial-Volume Effect Improves Detectability of Intractable Epileptogenic Foci on 123I-Iomazenil Brain SPECT Images
J. Nucl. Med., March 1, 2008; 49(3): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper
Molecular Neuroimaging: From Conventional to Emerging Techniques
Radiology, October 1, 2007; 245(1): 21 - 42.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
J. J. Lin, N. Salamon, A. D. Lee, R. A. Dutton, J. A. Geaga, K. M. Hayashi, E. Luders, A. W. Toga, J. Engel Jr, and P. M. Thompson
Reduced Neocortical Thickness and Complexity Mapped in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Cereb Cortex, September 1, 2007; 17(9): 2007 - 2018.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
B. Weber, J. Wellmer, M. Reuber, F. Mormann, S. Weis, H. Urbach, J. Ruhlmann, C. E. Elger, and G. Fernandez
Left hippocampal pathology is associated with atypical language lateralization in patients with focal epilepsy
Brain, February 1, 2006; 129(2): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Bartha, T Benke, G Bauer, and E Trinka
Interictal language functions in temporal lobe epilepsy
J. Neurol. Neurosurg. Psychiatry, June 1, 2005; 76(6): 808 - 814.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Bouvard, N. Costes, F. Bonnefoi, F. Lavenne, F. Mauguiere, J. Delforge, and P. Ryvlin
Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study
Brain, June 1, 2005; 128(6): 1330 - 1343.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, M. P. Richardson, R. Hurlemann, D. J. Brooks, and J. S. Duncan
Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients
Brain, June 1, 2003; 126(6): 1300 - 1318.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Rosati, Y. Aghakhani, A. Bernasconi, A. Olivier, F. Andermann, J. Gotman, and F. Dubeau
Intractable temporal lobe epilepsy with rare spikes is less severe than with frequent spikes
Neurology, April 22, 2003; 60(8): 1290 - 1295.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
P. Vermathen, K. D. Laxer, N. Schuff, G. B. Matson, and M. W. Weiner
Evidence of Neuronal Injury Outside the Medial Temporal Lobe in Temporal Lobe Epilepsy: N-Acetylaspartate Concentration Reductions Detected with Multisection Proton MR Spectroscopic Imaging--Initial Experience
Radiology, January 1, 2003; 226(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, R. Hurlemann, M. Thom, M. P. Richardson, D. J. Brooks, and J. S. Duncan
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI
Brain, October 1, 2002; 125(10): 2257 - 2271.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M. J. Koepp, M. P. Richardson, C. Labbe, D. J. Brooks, V. J. Cunningham, and J. S. Duncan
Central benzodiazepine receptors in malformations of cortical development: A quantitative study
Brain, August 1, 2001; 124(8): 1555 - 1565.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.